Literature DB >> 27576001

Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis.

Piya Sereerak1, Songkaid Upontain1, Prasarn Tangkawattana2, Frank F Mallory3, Banchob Sripa4, Sirikachorn Tangkawattana5.   

Abstract

Opisthorchiasis caused by Opisthorchis viverrini is a major food-borne zoonosis in Greater Mekong sub-region. Even though campaigns discouraging the consumption of raw fish have been launched to public, the disease still remains highly endemic. The unsuccessful eradication of the disease is probably because of the persistence of the parasite in animal reservoir hosts, particularly felids. Praziquantel (PZQ) is the drug of choice for morbidity control of opisthorchiasis in humans and animals. However, there is no specific study on its dosage regimen for feline opisthorchiasis. Thus, the effective treatment dose of PZQ, as well as its adverse effects, was evaluated in O. viverrini infected cats. Twenty-eight infected male and female cats from the endemic area of Khon Kaen and Maha Sarakham Provinces, Thailand were enrolled in this study. Physical, hematological, blood chemical and urine examinations were analyzed, as indicators of health status, on the day before and 30days after treatment. Intensity of the infections was determined by the formalin-ethyl acetate sedimentation technique. Cats were equally allotted into the low infection group of 14 cats with egg count per gram of feces (EPG) <300 and the high infection group of 14 cats with EPG higher than 300. Cats in each group were equally divided into two subgroups of 7 cats; thus, there were two low infection subgroups (L1 and L2 subgroups) and two high infection subgroups (H1 and H2 subgroups). A single dose of 25mg/kg PZQ was orally administered to each cat in the L1 and H1 subgroups and a single oral dose of 40mg/kg PZQ was administered to the L2 and H2 subgroups. Complete clearance of O. viverrini eggs was found in all cats in the L1, L2 and H2 subgroups; thus, the cure rate (CR) and egg reduction rate (ERR) were 100%. However, partial clearance was observed in two cats with high EPG (1502 and 1518) in the H1 subgroup, which received 25mg/kg PZQ. Regards, CR and ERR for these two animals was 71.4 and 99.5%. No significant difference among the 4 subgroups was seen. Almost all hematological, blood chemical and urinalysis data were within normal ranges, except for the eosinophilia and an increase of alanine aminotransferase (ALT). Hookworm infection seen in all cats would cause eosinophilia. As for drug safety, there was no side effect observed in any cats. In conclusion, this study suggested that 40mg/kg PZQ is a highly effective and safe dosage for the treatment of feline reservoir hosts of human opisthorchiasis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cat; Opisthorchiasis; Praziquantel; Reservoir host; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27576001      PMCID: PMC5326694          DOI: 10.1016/j.parint.2016.08.005

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  17 in total

1.  Opisthorchis viverrini and opisthorchiasis: the 21st century review.

Authors:  B Sripa; P Sithithaworn; S Sirisinha
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

2.  Liver flukes in dogs and treatment with praziquantel.

Authors:  R K Schuster; J Heidrich; A Pauly; K Nöckler
Journal:  Vet Parasitol       Date:  2007-11-05       Impact factor: 2.738

3.  Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis.

Authors:  B Sripa; S Kaewkes
Journal:  Int J Parasitol       Date:  2000-05       Impact factor: 3.981

Review 4.  Praziquantel.

Authors:  P Andrews; H Thomas; R Pohlke; J Seubert
Journal:  Med Res Rev       Date:  1983 Apr-Jun       Impact factor: 12.944

5.  High prevalence of Opisthorchis viverrini infection in reservoir hosts in four districts of Khon Kaen Province, an opisthorchiasis endemic area of Thailand.

Authors:  Surasit Aunpromma; Prasarn Tangkawattana; Pittaya Papirom; Prapan Kanjampa; Smarn Tesana; Banchob Sripa; Sirikachorn Tangkawattana
Journal:  Parasitol Int       Date:  2011-08-06       Impact factor: 2.230

6.  Studies on intestinal trematodes in Korea: XVIII. Effects of praziquantel in the treatment of Fibricola seoulensis infection in albino rats.

Authors:  Soon Hyung Lee; Jong Yil Chai; Byoug Seol Seo
Journal:  Kisaengchunghak Chapchi       Date:  1985-06

7.  Sustained-release praziquantel tablet: pharmacokinetics and the treatment of clonorchiasis in beagle dogs.

Authors:  Sung-Tae Hong; Sang Hyup Lee; Seung-Jin Lee; Weon-Gyu Kho; Mejeong Lee; Shunyu Li; Byung-Suk Chung; Min Seo; Min-Ho Choi
Journal:  Parasitol Res       Date:  2003-08-28       Impact factor: 2.289

8.  Results of toxicological studies on praziquantel.

Authors:  H Frohberg
Journal:  Arzneimittelforschung       Date:  1984

9.  The anti-schistosomal drug praziquantel is an adenosine antagonist.

Authors:  F Angelucci; A Basso; A Bellelli; M Brunori; L Pica Mattoccia; C Valle
Journal:  Parasitology       Date:  2007-04-12       Impact factor: 3.234

Review 10.  Liver fluke induces cholangiocarcinoma.

Authors:  Banchob Sripa; Sasithorn Kaewkes; Paiboon Sithithaworn; Eimorn Mairiang; Thewarach Laha; Michael Smout; Chawalit Pairojkul; Vajaraphongsa Bhudhisawasdi; Smarn Tesana; Bandit Thinkamrop; Jeffrey M Bethony; Alex Loukas; Paul J Brindley
Journal:  PLoS Med       Date:  2007-07       Impact factor: 11.069

View more
  1 in total

1.  Effectiveness of Repeated Administration of Praziquantel with Disodium Glycyrrhizinate and Two Enantiomers of Praziquantel on Opisthorchis felineus (Rivolta, 1884).

Authors:  D F Avgustinovich; M A Tsyganov; M Y Pakharukova; E N Chulakov; A V Dushkin; V P Krasnov; V A Mordvinov
Journal:  Acta Parasitol       Date:  2019-12-03       Impact factor: 1.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.